U.S. Markets open in 5 hrs 37 mins

Analyst Recommendations for Valeant Pharmaceuticals in July

Daniel Collins
Analyst Recommendations for Valeant Pharmaceuticals in July

In July, the FDA accepted Bausch + Lomb’s NDA (New Drug Application) for sub-micron loteprednol etabonate for the treatment of patients who have undergone ocular surgery and are showing symptoms of post-operative inflammation and pain.